Suven Pharmaceuticals announces today that the US Food and Drug Administration USFDA has issued an EIR for its wholly owned Subsidiary Casper Parma a finished dosage drug Manufacturer for human use The pre- approval inspection was conducted during 25 July 22 through 29 July 22 Pre-Approval Inspections covering of three applications NDA 016084 ANDA 217020 ANDA 217030 The inspection concluded with no observation FDA-483 issued EIR received from US FDA states that the site is recommended for approval of the three NDA ANDA listed above
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
